Lobbying as it relates to pharmaceutical pricing reforms under the Patented Medicines Pricing Review Board (PMPRB). The PMPRB has proposed a new regulatory framework (under Health Canada). Our lobbying efforts will be focusing on discussing alternatives to the proposed PMPRB framework.